Regulon

Regulon: R-283

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
91.98419110Pr-140Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9697 ENSG00000065308 TRAM2 Q15035
2000 ENSG00000102034 ELF4 Q99607
79073 ENSG00000110108 TMEM109 Q9BVC6
2335 ENSG00000115414 FN1 P02751
9695 ENSG00000134109 EDEM1 Q92611
10618 ENSG00000152291 TGOLN2 O43493
23102 ENSG00000167202 TBC1D2B Q9UPU7
254102 ENSG00000173442 EHBP1L1 Q8N3D4
2314 ENSG00000177731 FLII K7EP37

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
L19IL2FN1AntibodyBINDING AGENTFibronectin binding agent30
AS-1409FN1AntibodyBINDING AGENTFibronectin binding agent10
L19TNFAFN1AntibodyBINDING AGENTFibronectin binding agent20
L19SIP 131IFN1AntibodyOTHERFibronectin other20
OCRIPLASMINLAMA2EnzymePROTEOLYTIC ENZYMEFibronectin proteolytic enzyme40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-283

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-03048OR5D14up-regulatesRUNX1activatesR-283153Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-06930ATRXdown-regulatesRUNX1activatesR-283158Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-08599FOXR2down-regulatesRUNX1activatesR-283152Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-09342SPTA1down-regulatesRUNX1activatesR-283151Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-19408NF1up-regulatesRUNX1activatesR-283159Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-21662MUC17up-regulatesRUNX1activatesR-283158Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-22594IDH1down-regulatesRUNX1activatesR-283157Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-28413MYO9Bdown-regulatesRUNX1activatesR-283157Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-30634SALL4down-regulatesRUNX1activatesR-283155Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-30754POLRMTup-regulatesRUNX1activatesR-283154Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN